Class A CpG oligodeoxynucleotide inhibits IFN‐γ‐induced signaling and apoptosis in lung cancer

BACKGROUND: Currently, anticancer immunotherapy based on PD‐1/PD‐L1 blockade with immune checkpoint inhibitors (ICIs) is being used as a standard therapy for non‐small cell lung cancer (NSCLC). However, more effective treatments are required as these tumors are often resistant and refractory. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Teranishi, Shuhei, Kobayashi, Nobuaki, Katakura, Seigo, Kamimaki, Chisato, Kubo, Sousuke, Shibata, Yuji, Yamamoto, Masaki, Kudo, Makoto, Piao, Hongmei, Kaneko, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113052/
https://www.ncbi.nlm.nih.gov/pubmed/32067413
http://dx.doi.org/10.1111/1759-7714.13351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113052/
https://www.ncbi.nlm.nih.gov/pubmed/32067413
http://dx.doi.org/10.1111/1759-7714.13351

Ejemplares similares